# Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), Cambridge, MA – FDA Inspections

Source: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8

> Inspection records and compliance data for Alnylam Pharmaceuticals Inc. in Cambridge, Massachusetts. 3 FDA inspections on record, 2 Form 483s, last inspected February 25, 2025. Publicly traded as NASDAQ: ALNY.

---

## Details

- Name: Alnylam Pharmaceuticals Inc.
- FEI Number: 3013754451
- Address Line 1: 665 Concord Ave
- City: Cambridge
- State: Massachusetts
- Zip Code: 02138
- Country Name: United States
- Address: 665 Concord Ave, Cambridge, Massachusetts 02138, United States
- Country: United States

## Stock

- Stock ticker: ALNY
- Exchange: NASDAQ
- Share price: $156.65
- Market cap: $21.0B
- Price as of: November 13, 2026

## Related Documents

- [483 - Alnylam Pharmaceuticals Inc. - 2025-02-25](https://www.keypedia.com/records/483/alnylam-pharmaceuticals-inc/c1f4128d-8509-47ae-b160-11cecceecf5d) — source: FDA, date: February 25, 2025
- [FDA Inspection 1262276 - Alnylam Pharmaceuticals Inc. - 2025-02-25](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/f171eb1e-7893-4b06-a4b1-a428da24972b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 25, 2025
- FDA Inspection 1109687 - Alnylam Pharmaceuticals Inc. - 2019-09-13 — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2019
- [FDA Inspection 1050730 - Alnylam Pharmaceuticals Inc. - 2018-05-04](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/1691a345-79e1-4df1-8ec0-180e5d67002c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2018

## Related Companies

- [Conopco Inc. d/b/a Unilever](https://www.keypedia.com/companies/conopco-inc-dba-unilever/f742261e-b37a-43b6-afd4-98d63b24d0da)
- [SpecGx, LLC](https://www.keypedia.com/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f)
- [Cardinal Health 414, LLC](https://www.keypedia.com/companies/cardinal-health-414-llc/b1d6d59b-695c-42a4-8272-d3e5a96de306)
- [Quotient Sciences - Philadelphia, LLC](https://www.keypedia.com/companies/quotient-sciences-philadelphia-llc/21968347-fe31-4ffc-801c-5253fa909968)
- [United Therapeutic Corporation](https://www.keypedia.com/companies/united-therapeutic-corporation/fda8d6ce-d684-4496-89b6-5f8b526d83f7)
- [Zydus Pharmaceuticals Limited](https://www.keypedia.com/companies/zydus-pharmaceuticals-limited/a915c687-5359-4e95-b6bc-b2e6a506ca52)
- [Apotex Research Private Limited](https://www.keypedia.com/companies/apotex-research-private-limited/074db0b0-4f5f-4ee7-90e9-1c661c86f90c)
- [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76)
- [Amneal Complex Products Research LLC](https://www.keypedia.com/companies/amneal-complex-products-research-llc/a2be8996-ba6b-481d-b935-b75129500758)
- [AIAC International Pharma, LLC](https://www.keypedia.com/companies/aiac-international-pharma-llc/f2a0eb8d-93c0-4b7e-a46c-72f483b241c3)

## Related Officers

- [Ogechi C. Nna](https://www.keypedia.com/people/ogechi-c-nna/59452184-8197-4ba6-bf1d-78a7e003ef2c)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)